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Epidurals used for labor are common regional anesthesia techniques that are easily placed 
and controlled, while providing the most reliable method of pain relief in obstetrics for 
parturient women.  Local anesthetics, narcotics, and/or combinations of the two are 
administered through epidurals to treat labor pain.  Hence, the choice of medication is 
important, as it can highly influence outcomes of pain relief.  The purpose of this DNP 
project was to evaluate the effectiveness of a new service line medication, bupivacaine 
0.1% with fentanyl 2mcg/ml, to treat labor pain in parturient women at a rural community 
hospital in southern California guided by the Johns Hopkins Nursing Evidence Based 
Practice Model.  A quantitative, time-series, retrospective, and prospective design was 
used to analyze data from a convenience sampling of participants who received 
ropivacaine and bupivacaine with fentanyl.  Paired samples t-tests compared differences 
in verbal pain scores before and after epidural insertion with initial boluses alongside 
frequencies of top-off boluses required to achieve adequate pain relief.  Findings showed 
that both medications were equally effective in the treatment of labor pain within the first 
hour after the intervention.  However, the ropivacaine group had higher rebolus demands, 
while the bupivacaine with fentanyl group had only a minimal amount.  The complexity 
of healthcare today demands inter and intraprofessional collaboration to improve and 
sustain best outcomes for high quality care.  The bupivacaine with fentanyl project 
impacts social change by improving the quality of care for parturient women, addressing 
the fear and anxiety of childbirth pain, and highlighting the importance of collaboration 
with other clinical providers to change practice using the evidence.  
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Section 1: Overview of the Evidence 
Introduction 
Epidural analgesia for parturient women, is a common regional technique used 
during childbirth involving the use of local anesthetics, narcotics, and/or a combination of 
the two to decrease labor pain (Fehder & Gennaro, 1993).  Epidurals eventually replaced 
caudal anesthesia in the 1960’s because it was easier to control, easier to place, and had 
less inherent contamination risks (Fehder & Gennaro, 1993).   
Epidural analgesia offers the most reliable pain relief with the least amount of 
side effects for the longest period of time in labor when compared to all other forms of 
pharmacological methods (Pirbudak, Tuncer, Kocoglu, Goksu, & Celik, 2002).  
However, the choice of anesthetic medication is important and can highly influence the 
outcome of pain relief.  This DNP project evaluated the effectiveness of a new service 
line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, to treat labor pain in parturient 
women at a southern California hospital (SCH).  I provide an overview of the project, a 
review of best evidence, and outline how this medication in the treatment of labor pain 
will be measured and evaluated.  In section 1, I will discuss ropivacaine and 
bupivacaine’s pharmacological properties, its role in pain relief at SCH, the surrounding 
circumstances that led to the development of the practice initiative, problem statement, 
purpose statement, purpose objectives, purpose questions, significance to practice, and 
operational definitions.     
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Background/Context 
Ropivacaine and bupivacaine are two local anesthetics that are commonly used to 
treat labor pain with a wide amount of success (Pirbudak, Tuncer, Kocoglu, Goksu, & 
Celik, 2002).  Ropivacaine is a newer amide local anesthetic that is structurally similar to 
bupivacaine but has the reduced propensity to cause motor blocks and cardiotoxicity 
(Feldman & Covino, 1988).  With these added benefits, it has gained popularity in 
obstetrics for analgesia.  However, recent studies have suggested that ropivacaine 
administered epidurally is approximately 40% less potent than bupivacaine based on an 
index of 50% effective dose’ (Polley, Columb, Naughton, Wagner, & Van de Ven, 1999). 
Ropivacaine has been in use for approximately 1.5 years at SCH after 
discontinuation of bupivacaine 0.125% with fentanyl 1.6 mcg/ml.  Since the medication 
change, anesthesia peers and labor/delivery registered nurses (RNs) have voiced 
dissatisfaction.  Anesthesia peers stated that they had higher workload demands because 
parturients treated with ropivacaine often require more top off boluses of bupivacaine 
0.25% to provide adequate pain relief.  However, top off boluses are not long-term 
solutions and are only effective up to approximately 60 minutes (Zaric, Nydahl, & 
Philipson, 1996).  Labor and delivery RNs stated that patients who received ropivacaine 
solutions expressed higher verbal pain scores than previous patients who received 
bupivacaine.  In light of these observations, a recent medical decision was made to switch 
back to bupivacaine with fentanyl, albeit, a slightly lower concentration of bupivacaine 
was ordered to decrease the chances of adverse events and conversions to cesarean 
sections, which are often attributed to bupivacaine.  
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The labor and delivery unit at SCH is comprised of four laboring rooms, two 
triage beds, and one operating room.  The average monthly census ranges from 40 to 50 
parturient women who deliver vaginally, of which 78% receive epidural anesthesia for 
labor.  The national average is 61%.  After receiving permission from management, a 
retrospective chart audit was performed that focused on top-off bolus rates for all 
parturients who delivered in January 2014.  Results showed that at least half the patients 
with epidurals who received ropivacaine for labor required at least one top off bolus of 
additional local anesthetic between the time periods where the epidurals were placed and 
the fetus was delivered.  The results of the January audit revealed unusually high rates of 
top-off boluses that could indicate that ropivacaine was not highly effective in providing 
adequate pain relief.  Out of 46 parturient women with epidurals for labor, 22 parturient 
women required additional boluses.  Moreover, documented verbal pain scores were all 
above seven out of 10 on a numeric pain rating scale, which were reported to the 
anesthesia provider just prior to the top off bolus.    
Problem Statement  
Ropivacaine 0.2% administered for labor analgesia provided suboptimal relief for 
parturient women at SCH as noted by an increased number of patients’ requests for 
rescue boluses, higher verbal pain scores, and feedback from labor and delivery RNs and 
anesthesia staff as compared to the previous discontinued medication, bupivacaine 
0.125% with fentanyl 2mcg/ml.   
This problem is contrary to what the literature states in regard to analgesia used 
during labor.  Most studies indicated that ropivacaine administered through continuous 
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epidurals in equipotent doses was as effective as bupivacaine when used to treat labor 
pain (Dresner, Freeman, Calow, Quinn, & Bamber, 2000).  Although the prior 
ropivacaine solution used for labor analgesia was equipotent to the previous bupivacaine 
with fentanyl solution, it failed to produce adequate pain relief.  Ropivacaine was the 
medication used for labor analgesia from January 2014 to January 2015, while 
bupivacaine was the medication used prior to the switch.  A retrospective chart audit of 
top-off boluses and verbal pain scores in January 2013 of parturient women who received 
bupivacaine suggests that the medication is far more effective than ropivacaine.  Out of 
45 parturient women, only five required additional boluses.  Two out of those five 
parturient women had verbal pain scores above seven out of 10 on a numeric pain scale 
just prior to the bolus.        
Purpose Statement 
The purpose of this DNP project was to determine the efficacy of the new service 
line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, for the treatment of labor pain 
in parturient women at SCH.  The purpose was to create positive labor experiences for 
parturient women by treating labor pain with medications that have good safety profiles, 
are cost-effective, and require minimal to almost no additional top off boluses.  Effective 
pain relief medications will allow patients to allocate more quality time to other areas of 
labor such as breathing and relaxation techniques.  For healthcare providers, effective 
pain relief would decrease time demands in providing comfort measures, which may 
permit more time for coaching and individualized care.    
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Project Objectives 
There were two objectives for the project.  The first was to achieve verbal pain scores of 
the parturient women of less than four out of 10 post epidural insertion/initial loading 
dose within 60 minutes.  The zero through 10 numeric pain rating scale is a reliable 
diagnostic tool promoted by the National Initiative on Pain Control (NIPC) to assess the 
severity and quality of pain experienced by patients (McCaffery & Pasero, 1999).  
According to the numeric pain scale, pain scores that are less than four out of 10 indicate 
mild to almost no pain at all is a reasonable goal and will serve as the target threshold for 
this initiative.  Verbal pain scores were collected by the anesthesia provider 5 minutes 
prior to epidural insertion and 60 minutes post epidural insertion/initial loading dose 
administration and patient controlled epidural analgesia (PCEA) basal rate infusions. 
The second objective was to achieve a top-off bolus rate of less than 10%.  This 
figure was obtained taking into consideration the rebolus events based on retrospective 
chart reviews.  Bupivacaine 0.125% with fentanyl 2mcg/ml, the medication used prior to 
January 2014, had a rebolus rate of 11%.  Ropivacaine 0.2%, the medication used just 
prior to January 2015, had a rebolus rate of 48%.  Reboluses of additional local anesthetic 
introduce the potential for more adverse effects to the parturient woman and fetus, such 
as cardiotoxicity and delayed labor progression (Dresner, Freeman, Calow, Quinn, & 
Bamber, 2000).  Therefore, it would be more ideal to minimize the number of reboluses 
the parturient women receive.   
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Project Questions 
There were two project questions.  The first question asked: Does bupivacaine 
0.1% with fentanyl 2mcg/ml reduce labor pain to adequate levels safely and timely?  The 
goal was to achieve pain scores of less than four out of 10 on a numeric pain rating scale 
within 60 minutes post epidural insertion/initial medication bolus.  Bupivacaine 0.1% is a 
slightly lower concentration than the bupivacaine solution used in the past.  The risks of 
cardiotoxicity and adverse effects are decreased with lower concentrations.   
The second question asked: Does bupivacaine 0.1% with fentanyl 2mcg/ml 
provide sustainable labor pain relief where additional top off boluses are not required.  
The desired goal was a target threshold of less than 10% occurrence.  Decreased rates of 
additional boluses may indicate that parturient women have adequate and/or tolerable 
pain levels. 
Significance of the Project 
Evidence based practice (EBP) supports clinical practice by developing strategies 
according to the best available scientific evidence (Strand & Parkkinen, 2014).  The main 
role of the evidence is to associate causal inferences with the expected results from 
available interventions, thereby tying relevant causal knowledge to decision making in 
the clinical arena.  Therefore, a proper understanding of the precise content of the causes 
and the inferences they enter into are important.   
Although much of the medical literature notes that ropivacaine has a similar 
potency and duration to that of bupivacaine with less cardiotoxic effects (Dresner et al., 
2000), the reverse seems true at SCH.  Implementation of a bupivacaine initiative to 
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investigate its role in labor analgesia relief would add to the ever-increasing knowledge 
base aimed at providing high quality care at cost effective means.  Finding a suitable 
medication that would provide adequate analgesia needing less frequent rebolusing of 
additional local anesthetics improves quality of care by decreasing exposure of 
unnecessary medications to the parturient and relieving increased workloads on 
anesthesia personnel.   
Lastly, effective pain relief for parturient women can improve the overall birthing 
experience.  One study indicated that labor pain was directly associated with 
posttraumatic stress, which in turn had a correlation with patients’ overall birthing 
experiences (Garthus-Niegel, Knoph, Soest, Nielsen, & Eberhard-Gran, 2014).  Treating 
labor pain effectively would decrease posttraumatic stress episodes (Garthus-Niegel et 
al., 2014). 
Reduction of Gaps 
Childbirth is often accompanied by pain.  The overall goal of the bupivacaine 
with fentanyl initiative is to provide effective pain relief for parturient women safely, 
adequately, and promptly.  Labor pain relief is a major component of the birthing 
process.  Historically, pain management was often neglected because of societal 
expectations that women should endure the process without supplemental analgesics.  
However, traumatic labor experiences have been shown to cause psychologically 
detrimental effects (Campbell, 2003).  For example, ineffective pain relief highly 
influenced parturient women’s long-term decisions to have another baby (Iliadou, 2009).  
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Hence, the goal is to provide effective labor analgesia that would not dissuade parturients 
from future birthing experiences.   
Epidural insertion rates at SCH are approximately 78% as compared to the 
national average of 61% (Osterman & Martin, 2011).  Given SCH’s above national 
average epidural insertion rates, it makes prudent sense to consider the management of 
labor pain via the epidural method a high priority.  A reduction of gaps addresses the 
translation of evidence-based knowledge into clinical practice by use of techniques or 
modes of therapy that work.  To be useful, evidence should enable clinicians to practice 
better, meaning better outcomes and satisfaction for patients.  However, ropivacaine used 
for labor analgesia through continuous patient controlled epidural infusion in SCH’s 
population is an example where a medication did not work effectively based on 
healthcare provider feedback, high number of top-off boluses, and verbal pain scores 
from parturient women compared to patients that received bupivacaine with fentanyl.  
Evidence has pointed out that lower concentrations of bupivacaine and the addition of 
narcotics such as fentanyl can provide high quality analgesia with minimal side effects at 
cost effective means (Dresner et al., 2000).  As front line providers in the labor and 
delivery department, nurse anesthetists have a duty to provide prompt, effective, and safe 
labor analgesia relief so that parturient women receive the highest quality care and 
positive overall birthing experiences. 
Implications for Social Change 
Pain experienced in childbirth is a complex phenomenon that can trigger fear.  
Fear associated with childbirth is considered harmful, and has been shown to affect a 
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woman’s self-esteem and her ability to handle labor pain effectively (Karlsdottir, 
Halldorsdottir, & Lundgren, 2014).  In fact, studies have shown that women actually 
experience higher levels of labor pain than they had expected prior to the childbirth 
(Lally, Murtagh, Macphail, & Thomson, 2008; Iliadou, 2009).  Unmet expectations and 
negative birth experiences have been shown to influence women’s decisions about future 
childbearing (Gottvall & Waldenstrom, 2002).   
 The American Association of Colleges of Nursing (AACN) advocates for DNP 
practitioners to have a wide array of knowledge gleaned from the sciences and to be well 
prepared to translate that knowledge into the daily demands of clinical practice (AACN, 
2006).  Nursing science has created a large body of information that could guide nursing 
practice and has extended the scientific underpinnings of the discipline (AACN, 2006).  
Information received from this initiative would contribute to the body of nursing 
knowledge aimed at improving health care quality for the parturient woman and her 
family.  Epidurals placed for labor coupled with safe and effective medications can allay 
patients’ fears and anxiety during a significant period in their lives.  Treating labor pain 
effectively and informing parturient women adequately by addressing their concerns and 
presenting realistic expectations about epidural pain management may increase 
satisfaction surrounding the childbirth experience.  
Definition of Terms 
The following terms were used in this initiative concerning bupivacaine with 
fentanyl: 
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Anesthesia: A partial or complete loss of sensation for the purposes of surgery or 
medical procedure, with or without loss of consciousness (Barash et al., 2013).  
Epidural anesthesia: Anesthesia that is produced by the injection of local 
anesthetics into the peridural space outside the spinal cord, often used during childbirth 
delivery, lower extremity surgeries, and postoperative pain management (Morgan, 
Mikhail, & Murray, 2006). 
Evidence-based practice: A problem solving approach to clinical decision making 
that incorporates the best available evidence along with clinical expertise and patient 
preferences and values (Grove, Burns, & Gray, 2013).   
Labor pain: Crampy, diffused or localized lower abdominal pain, sometimes 
referred to the back and perineum coinciding with uterine contractions.  The pain may be 
supplemented with nausea, vomiting, and diaphoresis (Miller et al., 2005).  The 
operational definition of pain relief is defined as a verbal pain score of less than four out 
of 10 based on numeric pain rating scale ranging from zero to 10.  Zero is no pain 
whereas 10 is extreme pain.   
Patient controlled epidural analgesia: A technique of pain relief where a local 
anesthetic and opioid are administered by a pump into the epidural space allowing 
patients to self administer the analgesic mixtures on demand for supplemental doses in 
addition to the basal rate infusion (Miller et al., 2005).     
Rescue boluses: Supplemental local anesthetic medications of bupivacaine 0.25% 
ranging from six to eight milliliters that are administered via the epidural catheter by 
anesthesia providers to achieve pain relief for the parturient (Barash et al., 2013).   
  11 
 
Assumptions 
I made several assumptions about the success of the initiative.  First, the 
pharmacy at SCH would purchase or create enough supplies of the medication to meet 
the demand.  Second, the labor and delivery department and obstetricians would be 
supportive in efforts to address labor pain management.  Third, patients would have 
realistic expectations of what an epidural used for labor can and cannot do.  Fourth, 
patients would be honest in reporting their pain scores to providers.  Lastly, labor and 
delivery nurses would evaluate parturient women’s pain and notify the anesthesia 
provider of the need for top-off boluses.       
Limitations 
There were three limitations of the initiative that should be noted.  The first 
limitation related to inconsistent practices of all anesthesia providers.  All anesthesia 
providers have varying degrees of experience and different skillsets in the placement of 
epidurals.  There are several methods in the placement of epidurals such as the hanging 
drop technique, loss of resistance to air technique or the loss of resistance to saline 
technique (Morgan et al., 2006).  All have arguable advantages and disadvantages but a 
“gold” standard has not been established.   
 The second limitation pertained to consistent implementation and compliance of 
pre-procedural protocols performed by labor and delivery RNs.  Epidural placement is an 
invasive procedure that can have detrimental consequences for the parturient woman and 
fetus such as hypotension, excessive bleeding from the site, infection, spinal headaches, 
and even paralysis (Miller et al., 2005).  Hence, it was imperative that nurses followed 
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protocols that mitigated or eliminated the expected physiological effects of local 
anesthetics administered through epidurals.              
Lastly, one of the challenges of accurately measuring and treating labor pain was 
its subjective nature.  The verbal pain score based on Likert scales or numeric visual 
analog scales have been the most commonly used and trusted tools to measure subjective 
pain in subjects.  However, the health literacy of individuals and language barriers 
needed to be considered in pain assessment with those tools.   
Summary 
Epidural analgesia is the most reliable and longest lasting pain relief method with 
the least amount of side effects compared to all other forms of pharmacological methods 
for the birthing process.  Although the literature is saturated with studies that indicate that 
ropivacaine is equally comparable to bupivacaine in pain relief, it is not the case at SCH. 
In this section, I discussed the context of the problem in regards to labor pain 
relief at SCH, the initiative’s purpose and objectives, and the questions that are asked 
relative to those objectives.  Labor pain management is a high priority at SCH due to the 
above national average rates of epidurals used for childbirth.  Addressing the 
pharmacological agent that is responsible for unsatisfactory relief of labor pain is an 
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Section 2: Review of Literature and Theoretical/Conceptual Framework 
Introduction 
In section 2, I discuss the review of literature and search strategies that I 
performed to address the bupivacaine with fentanyl initiative.  At the end of the section, I 
present a theoretical/conceptual model that was utilized to help guide the project.  The 
Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) model focuses in depth on 
the evidence-based practice (EBP) process, which involves the identification of clinical 
practice questions, the discovery and evaluation of scientific evidence, and the translation 
of that evidence into clinical practice.     
General Literature Search 
I conducted a systematic literature review was done using PubMed, the 
Cumulative Index of Nursing and Allied Health (CINAHL), Medline, ProQuest Nursing 
and Allied Health Source, and Cochrane Database of Systematic Reviews.  Key search 
terms used were regional anesthesia, ropivacaine, bupivacaine, labor, postoperative 
analgesia, and epidural with limitations set to full-text.  A cumulative of 162 peer 
reviewed articles, books, and web domains were reviewed relevant to the topic.  One 
hundred and thirty-five of those sources were rejected because they were either published 
in languages other than English, were dated more than two decades, sample sizes were 
not reported or did not include explicit comparisons between ropivacaine and 
bupivacaine.  Inclusion criteria were that publications were peer-reviewed to assure a 
measure of quality, randomization of participants to either the bupivacaine or ropivacaine 
groups, and results reported allowed quantitative analysis.  Twenty-seven studies met the 
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project criteria and were included for the literature review.  The studies selected consisted 
of peer-reviewed articles, double-blind randomized controlled trials (RCT), meta-
analyses, prospective and retrospective studies, and case reports with initial publication 
dates of 1997.         
Specific Literature 
Most women experience severe pain with childbirth, similar to pain caused by 
complex regional pain syndromes or amputations of an extremity (Melzack, 1984).  
Although untreated pain is not life threatening in healthy parturient women, it can have 
severe neuropsychological consequences, such as posttraumatic stress disorder, postnatal 
depression, and impaired cognitive function in the postpartum period (Hawkins, 2010).  
Men are also affected by pain associated with labor.  Capogna, Camorcia, and Stirparo 
(2007) found that first-time fathers whose significant others who had received an epidural 
felt three times more helpful and involved and had less anxiety and stress compared to 
men whose significant others did not receive epidurals (Capogna, Camorcia, & Stirparo, 
2007).  The specific literature subsection will discuss epidurals for labor, patient 
controlled epidural analgesia, bupivacaine and ropivacaine profiles including motor block 
potential, cardiotoxicity, and potency, and the addition of narcotics to local anesthetics.     
Epidurals for Labor     
Effective pain relief coupled with minimal motor block are essential components 
of an ideal epidural for labor analgesia (Finegold, Mandell, & Ramanathan, 2000).  
Epidural analgesia for labor and delivery involves the use of a local anesthetic with or 
without the addition of an opioid into the lumbar epidural space (Catterall & Mackie, 
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2006).  The injected medications diffuse slowly across the dura and eventually bath the 
spinal nerve roots causing a decrease in catecholamine production and providing 
segmental sympathetic and sensory nerve blockades (Hawkins, 2010).  The resultant 
sensory nerve block is the relief of pain and the sympathetic block causes a reduction in 
vascular resistance significantly improving uteroplacental bloodflow in healthy 
parturients (Hawkins, 2010).  Increased bloodflow to the uterus and placenta ensures that 
the fetus receives adequate oxygenation and nutrition.      
Epidurals administered to provide effective labor pain relief have a longstanding 
history in obstetrics.  Studies comparing the effectiveness of epidurals to other modes of 
analgesic therapy, such as intravenous narcotics, were done with positive results 
favouring epidurals (Dickinson, Paech, Mcdonald, & Evans, 2003; Catterall & Mackie, 
2006; Hawkins, 2010).  One large trial study of 992 nulliparous women indicated 
significantly lower pain scores after the administration of epidural analgesia compared to 
those who received midwifery support (Dickinson, Paech, Mcdonald, & Evans, 2003).  In 
the study, pain scores were rated on a scale of zero to 100, with 100 being the worst pain 
imaginable based on a visual analog pain scale.  Median pain scores prior to the 
intervention were 80 in the midwifery group and 85 in the epidural group.  Post 
intervention median scores for the midwifery group were 75 and median scores for the 
epidural group were 27, indicating significant pain score reduction (p<0.001) (Dickinson 
et al., 2003).   
The study is important in pointing out that epidural analgesic techniques are 
significantly more effective in labor pain treatment than intravenous techniques.  The 
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bupivacaine with fentanyl initiative explored the efficacy of labor pain relief between two 
local anesthetic medications administered through epidurals, already established as the 
most efficacious and reliable method of analgesic therapy in labor.  The investigation of 
which medication was more effective will further add to the literature with the purposes 
of improving the quality of care in parturient women, while trying to minimize adverse 
consequences and negative outcomes.       
In a meta-analysis study involving 2703 nulliparous women who participated in 
five trials conducted in one facility, median pain scores were significantly reduced after 
interventions in the epidural group compared to the meperidine group (p<0.001) (Sharma, 
McIntire, Wiley, & Leveno, 2004).  Additionally, 95% of women in the epidural group 
rated their satisfaction with pain relief as excellent or good compared with 69% of 
women in the meperidine group (p<0.001) (Sharma et al., 2004).  After the 
administration of an epidural and an initial bolus of medication, effective maintenance of 
anesthesia can then be achieved through patient controlled epidural analgesia (PCEA) 
regimens.  The study showed that medications administered through epidural catheters 
via PCEA regimens was an effective way to treat labor pain.     
Patient controlled epidural analgesia regimens usually involve the dilution of local 
anesthetics with or without the addition of opioids administered through the epidural 
catheter with basal rate continuous infusions and patient controlled intermittent boluses 
(Lim, Ocampo, Supandji, Teoh, & Sia, 2008).  Some of the benefits of PCEA regimens 
are greater patient satisfaction, lower dose requirements of local anesthetics, reduced 
motor blocks, and fewer interventions by anesthesia personnel (Halpern & Joseph, 2002).  
  17 
 
Halpern and Joseph (2002) found in a meta-analysis of 640 patients in nine studies, that 
there were fewer overall anesthetic interventions in the PCEA group (95 percent CI, 
p<0.0001), less local anethestics infused (95 percent CI, p<0.0001), and less motor 
blocks (95 percent CI, p<0.003) compared to the continuous epidural infusion group 
(Halpern & Joseph, 2002).  Infusion rates and bolus amounts may be adjusted depending 
on individual variations to pain responses, stages of labor, and patients’ expectations 
about their childbirth experiences.  The two most commonly used local anesthetics 
administered through PCEA regimens are bupivacaine and ropivacaine.  Both 
bupivacaine and ropivacaine are administered via PCEA formats with continuous basal 
rate infusions through epidural catheters at SCH.  The DNP project showed that the 
addition of fentanyl allowed bupivacaine concentrations to be lowered, while providing 
effective analgesia and minimizing anesthesia interventions, such as, top-off boluses. 
Bupivacaine and Ropivacaine 
 Bupivacaine is the most commonly used medication administered for epidural 
analgesia in labor because of its widespread availability, low costs, and relative safety 
profile (Sah, Vallejo, Phelps, & Mandell, 2007).  It has a rapid onset and its duration is 
long-lasting.  Bupivacaine has also been shown to provide longer lasting analgesia than 
other local anesthetics even after sensations return (Catterall & Mackie, 2006).  However, 
claims of bupivacaine’s longer duration of analgesia are controversial.  Muir, Writer, and 
Douglas (1997) posited that a ropivacaine 0.25% group (n=34) and a bupivacaine 0.25% 
group (n=26) had no significant differences in the onset times of pain relief, quality of 
analgesia, and duration of analgesia in a prospective, double-blind, randomized multi-
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center study of 60 nulliparous labouring women when medications were administered 
epidurally by intermittent top-ups (95 percent CI, p<0.001).  Although the study showed 
the efficacy of labor pain relief through intermittent boluses of ropivacaine and 
bupivacaine, the results indicated that both medications had nearly identical outcomes.  In 
fact, the bupivacaine concentration used in the study is more than twice the concentration 
used in the DNP project, while ropivacaine concentrations are similar.  The DNP project 
showed that decreased bupivacaine concentrations with the addition of opioids provided 
effective labor pain relief as compared to moderate concentration levels of ropivacaine.          
Sah, Vallejo, Phelps, and Mandell (2007) later added that there were no 
significant differences in visual analog pain scores and Bromage scores in the measured 
time intervals between ropivacaine and bupivacaine.  In their prospective, randomized, 
double-blind study, 100 American Society of Anesthesiologists (ASA) physical status I 
and II, full-term, nulliparous women were placed into two groups, bupivacaine (n=50) 
and ropivacaine (n=50), and received initial boluses of medication and a continuous 
infusion of local anesthetics, either ropivacaine 0.2% or bupivacaine 0.125%.  The 
average onset time to achieve a T10 level sensory level block in the bupivacaine group 
was 11 minutes as compared to the ropivacaine group, which was 9 minutes.  Although 
the difference was statistically significant (p<0.05), it was clinically irrelevant.  The 
medication concentrations used in the study are almost identical to the medication 
concentrations in the DNP project.  The study results are important in pointing out that 
pain scores and motor block effects are similar.  The DNP project added further evidence 
to the study by comparing similar concentrations in a different population sampling.                          
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Modern obstetric analgesia teams aim to minimize motor blocks while eliminating 
the perception of pain from cervical dilation and uterine contractions (Lacassie, Habib, 
Lacassie, & Columb, 2007).  Ropivacaine is an amide local anesthetic that has gained 
popularity over the years in obstetric epidural analgesia due to its reduced propensity for 
causing cardiotoxic effects and its greater affinity for sensory fibers compared with 
bupivacaine (Feldman & Covino, 1988).  Thus, ropivacaine would be a more ideal 
medication choice in the labor and delivery ward.  In a toxicology human study, 
ropivacaine proved less toxic than bupivacaine when administered by intravenous 
infusion with regards to signs and symptoms of mild central nervous system and 
cardiotoxic effects (Katz, Bridenbaugh, Knarr, Helton, & Denson, 1990).  However, the 
cardiotoxic effects were often attributed to high concentrations of bupivacaine, such as 
0.75%, and have been discontinued across all clinical settings (Albright, 1984).  
Bupivacaine solutions of 0.75% are not available or utilized at SCH.  The DNP project 
used a bupivacaine solution that was 6.5 times less concentrated, therefore neurotoxicity 
and cardiotoxicity issues was a negligible factor.     
Chang, Ladd, and Copeland (2001) performed comparative studies of the direct 
effects of bupivacaine and ropivacaine on sheep hearts.  Doses ranging from trivial to 
toxic amounts were administered to explore what humans would receive if the injections 
were accidently administered via intravenous routes.  The findings indicated that both 
ropivacaine and bupivacaine have similar abilities to cause fatal cardiac arrhythmias and 
death (Chang, Ladd, & Copeland, 2001).  Although ropivacaine produced less 
myocardial depression and arrhythmias in the study, its lower potency requires higher 
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concentrations to achieve equianesthetic doses to those of bupivacaine, thereby offsetting 
its intrinsic cardiac toxicity profile.  The DNP project explored the efficacy of labor pain 
relief between ropivacaine 0.2% and bupivacaine 0.1% with fentanyl 2mcg/ml.  If higher 
concentrations of ropivacaine are needed just to equal the analgesic effects of lowered 
concentrations of bupivacaine at SCH, cardiotoxic and neurotoxic profiles of ropivacaine 
increase.  Thereby, the safety benefits of ropivacaine are dampened, risks for the 
parturient woman increase, and costs for the facility escalate.               
The perceived advantage of a reduced motor block potential is another popular 
belief in the push for ropivacaine in obstetrics.  Despite the expected advantages of 
reduced motor blocks due to reduced potencies, especially for childbirth, earlier studies 
that compared ropivacaine with bupivacaine for epidural analgesia for women in labor 
showed no significant benefits when administered through intermittent top-ups, 
continuous infusion, and continuous infusion with patient controlled top-ups (Eddleston 
et al., 1996; Owen, D’Angelo, & Geranchar, 1998).  Finegold, Mandell, and Ramanathan 
(2000) further expanded on the notion that different intensities of motor block were 
clinically similar in labor outcomes in a double-blind, randomized, 100 parturient study 
in patients who received ropivacaine or bupivacaine.  The researchers argued that 
although the bupivacaine group had 25% higher levels of motor block within the first 
hour of medication administration, outcomes of successful delivery were similar 
(Finegold et al., 2000).  Interestingly, out of the ropivacaine group (n=50), 11 parturient 
women had to deliver via caesarean section versus eight patients in the bupivacaine group 
(n=50)(Finegold et al., 2000).  Although it is not the focus of the DNP project, the 
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findings of the project showed that bupivacaine’s motor blocking effects was a nonissue 
in the context of labor outcomes at SCH.             
Since the introduction of ropivacaine into clinical practice, its potency has been 
an issue.  In one prospective, double-blind, randomized control trial of 126 single-term, 
ASA physical statuses I and II parturient women, potency ratios for 
ropivacaine:bupivacaine was statistically significant favouring bupivacaine (p<0.001).  It 
was suggested that ropivacaine has a 0.6 relative potency rating to that of bupivacaine.  
Researchers have suggested that ropivacaine is approximately 40% less potent than 
bupivacaine (Capogna, Celleno, Fusco, Lyons, & Columb, 1999; Dresner et al., 2000; 
Chua, Sia, & Ocampo, 2001).  Hence, large doses of ropivacaine would still be needed to 
evoke equal responses to that of lower doses of bupivacaine.  If large doses of 
ropivacaine are needed to match the potency of bupivacaine, the intended benefits of 
safety are lost.  Moreover, higher concentrations and bulk supplies of ropivacaine are 
more than twice the purchase costs of bupivacaine with fentanyl.  It was also 
hypothesized that ropivacaine would provide a better quality of analgesia because of its 
lower potency and a more theorized rostral spread of the anesthetic.  However, pain relief 
and cephalad spread between ropivacaine and bupivacaine were found to have similar 
results (Lacassie et al., 2007).  Ropivacaine’s concentration at SCH was 0.2%, considered 
equipotent to bupivacaine 0.125% by a vast majority of researchers in the literature 
(Capogna et al., 1999; Dresner et al., 2000; Owen et al., 1998).  The bupivacaine with 
fentanyl initiative adds to the literature in distinguishing whether the potency of 
ropivacaine is a factor in labor pain relief even at equipotent doses.                
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The majority of studies suggest that ropivacaine and bupivacaine have equivalent 
effects of labor analgesia relief in parturients (Chua, Sia, & Ocampo, 2001; Polley, 
Columb, Naughton, Wagner, & Van de Ven, 1999; Dresner et al., 2000; Fehder & 
Gennaro, 1993).  Although few, there are some conflicting studies that indicate better 
duration and quality of labor analgesia relief when bupivacaine is used compared to 
ropivacaine (Merson, 2001; Capogna et al., 1999).  However, the cited cause of 
bupivacaine’s effectiveness in the treatment of labor pain was attributed to the mixture of 
opioids.  The addition of an opioid to local anesthetic solutions can help treat missed 
segments, perineal pressure, and maximize efficacy and maternal satisfaction (Dresner et 
al., 2000) while promoting the idea that smaller doses of anesthetics infused translates 
into better safety profiles and decreased incidences of adverse effects.  Animal studies 
suggest that local anesthetics and opioids have a synergistic effect and that the binding of 
opioid receptors hyperpolarizes the membranes thereby decreasing nerve impulse 
transmissions (Melzack, 1984).  However, some of the drawbacks of adding opioids to 
local anesthetics include pruritus, hypotension, neuraxial infections, urinary retention, 
vomiting, and respiratory depression (Bucklin, Chestnut, & Hawkins, 2002).  When it 
comes to the addition of opioids to local anesthetic solutions, factors such as those listed 
previously should be taken into consideration depending on the context of the situation.  
The initiative showed that the addition of fentanyl, a potent opioid, to low concentrations 
of bupivacaine was a solution to providing high quality labor analgesia at safe, cost-
effective means at SCH.            
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General Literature 
Ropivacaine and bupivacaine are also used for other purposes alongside maternal 
labor – mainly postoperative pain control for patients who undergo lower limb, 
orthopedic, gynecological, and abdominal surgeries.  Postoperative pain management is a 
key component of anesthetic practice because untreated pain can be detrimental 
(Apfelbaum, Chen, Mehta, & Gan, 2003).  Effective treatment of pain helps restore 
normal physiological processes such as ventilation and coughing, which thereby 
promotes early ambulation, prevention of infections, and shortened hospital stays 
(Sawhney et al., 2015).   
Until recently, bupivacaine was the most commonly used medication for the 
management of postoperative epidural analgesia.  The toxic effects of bupivacaine on the 
central nervous system and cardiovascular system are less harsh with ropivacaine when 
plasma levels are comparable (Casati & Baciarello, 2006).  However, the claim that 
ropivacaine produces less motor block while providing equivalent analgesia compared to 
bupivacaine is also controversial outside of maternal analgesia (Merson, 2001).  Berti, 
Fanelli, Casati, and Albertin (2000) compared the analgesic efficacy and incidences of 
motor block during patient supplemented epidural analgesia with either 
ropivacaine/fentanyl or bupivacaine/fentanyl solutions in patients that underwent major 
abdominal surgeries.  In the prospective, double-blind, randomized study of 32 ASA 
physical status I-III patients, both ropivacaine/fentanyl and bupivacaine/fentanyl mixtures 
provided similar relief of analgesia, motor block, levels of sedation, and pulse oximetry 
readings (Berti, Fanelli, Casati, & Albertin, 2000).  A more recent study compared both 
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ropivacaine and bupivacaine for lower extremity orthopedic procedures, which indicated 
that there were no significant differences in block parameters (Chandran, Hemalatha, & 
Viswanathan, 2014).  In another prospective, double-blind, randomized trial of 60 
patients that underwent total knee replacements, findings suggested that there were no 
statistically significant differences in pain, side effects, and motor block between 
ropivacaine/morphine and bupivacaine/morphine groups (p<0.05)(Zaric, Christiansen, 
Haastrup, & Sandberg, 2004).  Although it is desirable to have patients ambulate almost 
immediately after total knee replacement surgeries, the findings indicate that earlier 
mobilization with the use of ropivacaine compared to bupivacaine are indistinguishable.  
It is then when the cost factor analysis also comes to question.   
At a time when facilities face economic constraints, cost-effectiveness should be 
taken into account when any new agents are considered.  In one study, an economic 
evaluation of bupivacaine with fentanyl versus ropivacaine alone administered for post 
operative pain control after total knee replacements showed that bupivacaine with 
fentanyl was more cost-effective and provided more patient satisfaction than ropivacaine 
because it provided better quality of analgesia (Pitimana-aree, Visalyaputra, Komoltri, 
Muangman, & Al, 2005).  Results indicated that the bupivacaine/fentanyl group (n=35) 
had higher pain satisfaction scores and an eighteen percent cost savings compared with 
the ropivacaine group (n=35).  Ropivacaine is approximately double the price of 
bupivacaine on an equipotent basis.  Facilities should perform sensitivity analyses to 
make reliable comparisons of medications. 
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Theoretical/Conceptual Framework 
The Johns Hopkins Nursing evidence-based practice model (JHNEBP) was used 
as the framework for the project.  The conceptual model consists of three major 
components of practice, research, and education (Buchko & Robinson, 2012).  The model 
points out that research and non-research factors form the basis for clinical decision-
making.  The Johns Hopkins Nursing evidence-based practice model also indicates that 
both internal and external factors should be taken into consideration before a certain 
practice can be changed (Buchko & Robinson, 2012).  The three phases of the model are 
practice question (P), evidence (E), and translation (T) (Buchko & Robinson, 2012).  In 
the first phase, a practice question is identified and explored.  The second phase involves 
a systematic review and synthesis of research and non-research components/factors 
(Buchko & Robinson, 2012).  The synthesis may include all types of research studies and 
all types of non-research factors, such as, experience, quality improvement and financial 
data, clinical expertise, and patient preferences.  The third phase is translation, where the 
evidence-based practice team can determine if new practice guidelines or interventions 
can be implemented or are feasible for implementation (Buchko & Robinson, 2012).  The 
translation phase includes possibly piloting the study, measuring outcomes, and 
disseminating the findings (Buchko & Robinson, 2012).  The model may shed light on 
relative potencies of the medications, financial costs, and additional solutions. 
The Johns Hopkins Nursing evidence-based practice model (JHNEBP) and its 
three step process, PET, was used to help guide the bupivacaine with fentanyl project by 
providing a straightforward, problem-solving approach designed to meet the needs of the 
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practicing nurse by incorporating most recent research findings and best practices.  The 
first step is the practice question.  For the project, effective labor analgesia relief is the 
topic of interest and which medication is considered more effective in providing labor 
pain relief, ropivacaine or bupivacaine with fentanyl.  The second step is concerned with 
the evidence that pertains to both research and non-research factors.  Research evidence 
deals with information that is derived from ropivacaine/bupivacaine controlled trial 
studies, case reports, meta-analyses, and other widely published forms of dissemination.  
Non-research evidence includes specific information obtained from the project itself, 
such as, provider and patient feedback, verbal pain scores, and number of top-off boluses.  
The third step focuses on translation where the new practice change is evaluated to 
determine if it is feasible for implementation and whether it is sustainable.  Financial and 
cultural factors are two issues that may be taken into consideration.  For example, would 
the new medication cost the institution more revenue and would there be purchasing 
issues?  Would every anesthesia provider be open to administering the new medication?  
Summary 
 Bupivacaine is a popular local anesthetic that is used in obstetrical anesthesia due 
to its superior analgesic effects.  It has a long-standing, successful track record and a 
wide variety of uses alongside maternal labor, such as, orthopedic and abdominal 
procedures.  However, its cardiotoxic effects in high concentrations have pushed for the 
creation of an isomer, ropivacaine.  The main advantage of ropivacaine is its wide margin 
of safety and motor sparing effects, something that is attractive in obstetrical anesthesia.  
Most studies indicate an equivalent analgesic effect when ropivacaine and bupivacaine 
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are compared to each other.  Decreased potencies, lesser quality of analgesia relief, and 
high costs of ropivacaine have been its crutch in a time where health care facilities look 
for cost-effective means to provide high quality care.  Although a majority of the 
evidence seems to suggest that ropivacaine causes less motor block and has less 
cardiotoxic and central nervous system effects, the benefits are offset by its decreased 
potency.  To achieve equipotent doses to that of bupivacaine, higher doses of ropivacaine 
are necessary, which would then increase costs.  Facilities would need to perform a 
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Section 3: Methodology 
Introduction 
 
Section 3 includes the methodology that I utilized to explore the effectiveness of 
the new service line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, administered 
via PCEA infusion in parturient women at SCH.  There were two objectives for the 
project.  The first objective was to achieve verbal pain scores of less than four out of 10 
on a numeric pain scale ranging from zero to 10 within 60 minutes of epidural insertion 
and initial loading dose.  The second objective was to achieve a rebolus rate of less than 
10% throughout the remainder of the course of labor until the delivery of the fetus.  The 
project design, population and sampling, data collection, instruments, data analysis, 
protection of human subjects, and project evaluation plan will also be discussed. 
 
Project Design 
I used a prospective, time-series, quantitative design was used to explore the 
efficacy of a new service line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, in 
parturient women.  I used a quantitative design because of its focus on patient groups and 
patterns that are unique to this special group, its investigation of the effectiveness of an 
intervention where outcomes are measureable, such as, verbal pain scores, and its ability 
to establish correlational or causal relationships between variables.  Verbal pain scores 
before and after the intervention and number of top-off boluses are quantifiable and can 
be analyzed statistically to determine if there are clinically significant differences 
between the variables: ropivacaine and bupivacaine.   
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Ropivacaine was discontinued at SCH in January 2015.  Therefore, data about the 
effects of ropivacaine on laboring parturients was obtained retrospectively from archived 
patient records that were electronically scanned.  Verbal pain scores that were reported to 
the anesthesia provider just prior to the bolus and an hour after epidural administration 
and initial bolus was recorded and statistically analyzed through paired samples t-tests to 
determine clinically significant differences.  Moderate to high occurrences of rebolus 
rates coupled with high verbal pain scores indicated that ropivacaine was not effective in 
relieving labor pain because verbal pain scores remained high necessitating supplemental 
local anesthetics.  Bupivacaine with fentanyl was concurrently started along with 
ropivacaine in January 2015.  Data such as numerical verbal pain scores, top-off boluses, 
epidural insertions, medication administration, preprocedural assessments, consents, and 
all other relevant data for the initiative were obtained and performed by one provider 
prospectively for 1 month.   
Population and Sampling 
The initiative focused on all parturients in the Morongo basin community 
admitted for labor at a 55-bed rural community hospital in Southern California.  Both 
retrospective and prospective portions of the initiative had inclusion/exclusion criteria.  
The inclusion criteria for all parturients was that they will be American Society of 
Anesthesiologist’s (ASA) physical statuses I or II; less than 100 kilograms in weight; less 
than 40 years old; cervically dilated less than five cm; and, have no previous history of 
cesarean section(s).  The retrospective component of the initiative was based on a1-
month chart audit convenience sampling of parturient women who received epidurals 
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from multiple providers and were placed on ropivacaine solutions.  The prospective 
component of the initiative was based on a 1-month convenience sampling of parturient 
women who labored at SCH, received epidurals from one anesthesia provider, and were 
placed on bupivacaine with fentanyl solutions.  Both retrospective and prospective 
portions of the initiative were based on non-probability sampling methods due to the low 
number of deliveries at the facility coupled with project completion time constraints. 
Data Collection 
I collected the entire data set for both retrospective and prospective components 
of the initiative.  The retrospective component involved chart audits accessed through 
“idoc”, a computer program where past medical records were scanned and saved onto 
password protected computer files.  First, the delivery room register was reviewed for 1 
particular month.  In the register, I noted the methods of delivery, anesthesia provider 
name, patient names, dates, and times of delivery.  I filtered out any parturient women 
who did not have epidurals and did not deliver vaginally through the delivery register 
initial screening.  Second, I used the medical record numbers of the parturient women to 
bring up their medical information on idoc.  I obtained initial and post epidural verbal 
pain scores, top-off boluses, preanesthetic health and physical information, vital signs, 
and list of medications.  Third, once the information was obtained, I deidentified all 
parturient women and assigned numerical codes.      
The prospective portion included the same data as the retrospective portion of the 
initiative.  However, the prospective component followed one standard technique by one 
anesthesia provider.  I performed a preanesthetic evaluation to collect information about 
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health and physical histories.  I then assigned an ASA physical status to the patient along 
with a numerical code at the conclusion of the interview.  Then, a total of one liter of 
Lactated ringer’s solution was given intravenously to every parturient woman 30 minutes 
prior to epidural insertion.  During the intravenous bolus, I presented the numeric pain 
rating scale depicted on a chart visually and discussed the chart to ensure understanding 
about verbal pain scores.  The numeric pain rating scale ranged from zero to 10.  Zero 
was equated with no pain while 10 was the equivalent of the worst pain imaginable.  
Once an adequate understanding of verbal pain scores was addressed, I recorded a pre-
block score.  I used the loss of resistance to saline technique to locate the epidural space 
at the L3-4 or L4-5 interspace with the parturient woman in the sitting position using a 
seventeen-gauge Tuohy needle (Braun).  Following epidural insertion and initial bolus, 
all parturient women were placed in the left uterine displacement position for 
approximately 1 hour.  Verbal pain scores were obtained 5 minutes prior to epidural 
insertion and 1 hour post epidural insertion and initial medication bolus.  I obtained data 
on additional top off boluses of bupivacaine 0.25% until delivery of the fetus. 
Instruments 
 I used two instruments for the initiative.  The first instrument was the facility’s 
preanesthetic evaluation form, which contained information about the health and history 
of patients.  Comorbidities, surgical histories, allergies, and heights/weights of the 
patients were examples of some of the information that was tabulated and then assigned 
an ASA physical status.  Participants that were healthy to fairly healthy, ASA statuses of 
  32 
 
I or II, were included for the initiative.  This information can be found in SCH’s 
preanesthetic record (Appendix A). 
 The second instrument I used was a visual/verbal analog scale that depicted a pain 
score on a horizontal line from zero to 10, zero being no pain and 10 being the worst pain 
imaginable (Appendix B).  Visual analog scales are frequently used to measure self-
reports of fear and pain in both children and adults (Chapman & Kirby-Turner, 2002).  
The measures for the initiative were simplified to only include verbal pain scores ranging 
from zero to 10.    
Protection of Human Subjects 
 I sought approval from administration, the chief compliance officer of SCH, and 
Walden University’s internal review board (IRB) before initiation of the project.  I 
reassured all participants in the prospective group about the purposes of the project and 
that intervention strategies were not different from the standardized norm.  Data collected 
for the initiative were readily accessible only to me and stored in confidential computer 
files protected by an encrypted password.    
Data Analysis 
I used a paired samples t-test to determine the significance between bupivacaine 
with fentanyl and ropivacaine and the adequacy of pain relief based on verbal pain scores 
collected pre and post intervention.  Paired samples t-tests are parametric analyses that 
compare mean differences in the same group of subjects at two different points in time 
(Polit, 2010).  However, the paired samples t-test requires that paired score differences 
are independent and normally distributed (Grove et al., 2013).  Frequency distributions 
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were used to determine top-off bolus rates of parturient women who receive bupivacaine 
with fentanyl or ropivacaine.  Statistical analysis was performed using SPSS Version 21 
for MAC, and significance levels of p < 0.05.  
There were two project questions.  The first project question asked: Does 
bupivacaine 0.1% with fentanyl 2mcg/ml reduce labor pain to adequate levels safely and 
timely?  The retrospective portion of the initiative addressed the efficacy of ropivacaine 
in labor pain relief by comparing verbal pain scores obtained 5 minutes prior to the 
epidural/initial bolus and verbal pain scores obtained 60 minutes post epidural/initial 
bolus.  Likewise, in the prospective component of the project, verbal pain scores were 
collected 5 minutes prior to and 60 minutes after the intervention.  The goal was to 
achieve pain scores of less than four out of 10 on a numeric pain rating scale within 60 
minutes post epidural insertion/initial medication bolus.  Lower pain scores after the 
intervention indicated whether the intervention was effective in relieving labor pain 
initially.        
The second question asked: Does bupivacaine 0.1% with fentanyl provide 
sustainable labor pain relief where additional top off boluses are not required?  The 
desired goal was a target threshold of less than 10% occurrence.  Decreased rates of 
additional boluses may indicate that parturients have adequate and/or tolerable pain levels 
and the medication provides sustainable labor pain relief negating the need for epidural 
replacements or rescue analgesics.  The number of top-off boluses required to obtain 
labor pain relief were recorded from the retrospective portion of the project from 
parturient women who received ropivacaine.  Similarly, the number of top-off boluses 
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required to obtain adequate labor pain relief were recorded from the prospective 
component of the project from parturient women who received bupivacaine with 
fentanyl. 
Project Evaluation 
 I used an evaluation plan was used to determine if ropivacaine and bupivacaine 
with fentanyl solutions provided adequate labor pain relief and discussed the strengths 
and limitations of the project.  The use of a summative evaluation was appropriate for the 
bupivacaine with fentanyl initiative because it scrutinized program outcomes to 
determine the effectiveness of interventions (Spaulding, 2008).  I used the summative 
evaluation to address three aspects important to the project: Intended goals of the project, 
anticipated outcomes, and intended/unintended impact and a goals evaluation to address 
project questions by determining if the two medications, ropivacaine and bupivacaine 
with fentanyl, adequately decrease verbal pain scores and minimize top-off boluses, 
thereby, providing sustainable labor pain relief during childbirth.  I used an outcomes 
evaluation to explore whether the program caused palpable effects on specifically defined 
target outcomes in parturient women.  I used an impact evaluation to provide a broader 
assessment of how the initiative affected the organization or community.  After the 
collection and analysis of data, I evaluated whether: (a) Ropivacaine and/or bupivacaine 
with fentanyl were indeed effective in providing adequate, sustainable relief of labor pain 
for parturient women in the Morongo basin community; (b) the sample population was 
representative of the community district; (c) patient and hospital personnel were satisfied 
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with the service provided; and (d) what processes could be improved upon to better the 
outcomes. 
Summary 
 In the bupivacaine with fentanyl initiative, I explored the efficacy of ropivacaine 
and bupivacaine with fentanyl utilizing both retrospective and prospective, time-series, 
quantitative designs.  Data gathered from the participants were analyzed through 
statistical analysis to determine clinically significant relationships of verbal pain scores 
pre and post epidural insertion and initial medication bolus.  The long-term efficacy of 
each medication was determined by the analysis of number of top-off boluses that 
parturient women received.  Participant protection rights were addressed by obtaining 
permission from the facility’s administration, chief compliance officer, and Walden 
University’s IRB.  A summative evaluation plan was used to determine if ropivacaine and 
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Section 4: Findings, Discussion, and Implications 
Introduction 
The purpose of this DNP project was to determine the efficacy of the new service 
line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, as compared to the 
discontinued medication, ropivacaine 0.2%, for the treatment of labor pain in parturient 
women at SCH.  The effectiveness of ropivacaine and bupivacaine with fentanyl in the 
treatment of labor pain was determined through retrospective, time-series, quantitative 
analysis and prospective, time-series, quantitative analysis, respectively.   
I implemented the project at a rural community hospital in the Morongo Basin 
area located in Southern California.  The bupivacaine with fentanyl proposal was first 
presented to the anesthesia, obstetrical, and surgical departments because ropivacaine 
0.2% administered for labor analgesia seemed to provide suboptimal relief for parturient 
women as noted by an increased number of patients’ requests for rescue boluses, higher 
verbal pain scores, and feedback from labor and delivery nurses and anesthesia staff as 
compared to the previous discontinued medication, bupivacaine 0.125% with fentanyl 
1.6mcg/ml.  The focus of this section will be on project findings, practice implications, 
project outcomes, project strengths and limitations, and a personal self-analysis relative 
to the project.  
Summary and Evaluation of Findings  
My goal in conducting this project was to evaluate the effectiveness of a new 
service line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, to treat labor pain in 
parturient women at SCH by investigating two questions.  Does bupivacaine 0.1% with 
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fentanyl 2mcg/ml reduce labor pain to adequate levels safely and timely and does 
bupivacaine 0.1% with fentanyl 2mcg/ml provide sustainable labor pain relief where 
additional top off boluses are not required?  To address the project questions, the 
following objectives were recognized:  
1. To achieve pain scores of less than four out of 10 on a numeric pain rating 
scale within 60 minutes post epidural insertion/initial medication bolus.   
2. To decrease rates of medication rebolusing of less than 10% occurrence. 
I incorporated a quantitative, time-series design to determine causal or 
correlational relationships between the independent and dependent variables.  Statistical 
analysis was done through SPSS version 21.0 to determine relationships between the 
independent variables, ropivacaine and bupivacaine with fentanyl, to the dependent 
variables, verbal pain scores and number of top-off boluses.  The numeric pain rating 
scale was used to determine the efficacy of the medications by analyzing the assigned 
value of scores before and after epidural placement.  A value of zero indicated no pain 
while a value of 10 indicated severe or worst imaginable pain.  The participants voiced 
understanding after initial instruction just prior to the epidural placement and were asked 
to give an initial score.  The participants were asked to give a follow up score 60 minutes 
after the initial bolus and continuous delivery of medication via patient controlled 
epidural analgesia (PCEA) pumps.   
Project Objective 1 
 Thirty-two participants were included in the ropivacaine group for analysis.  
There were a total of 48 deliveries of which 16 participants underwent caesarean section 
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and six parturient women did not meet the inclusion/exclusion criteria due to age, weight, 
and ASA physical statuses.  Ages of the participants ranged from 18 to 36 years old with 
a mean age of 25.3 (Table 1).  All parturient women in the ropivacaine group were 
interviewed prior to epidural placement with the use of the preanesthesia evaluation form 
(Appendix A).   
 Twenty-nine participants were included in the bupivacaine with fentanyl group 
for analysis.  A total of 33 parturient women received epidurals for labor.  However, 4 
parturient women did not meet inclusion/exclusion criteria either because of age, weight, 
physical ASA status, or conversion to cesarean section.  Ages of the participants ranged 
from 19 to 33 years old with a mean age of 25 (Table 1).  All parturient women in the 
bupivacaine with fentanyl group were interviewed prior to the placement of an epidural 
using the same preanesthesia evaluation form (Appendix A).   
Table 1 
Mean ages of parturient women 
 Minimum Maximum Mean 
Ropivacaine group 








Numerical pain scores before and after the intervention and number of top-off 
boluses were recorded on the first page of the anesthetic record (Appendix A).  A paired 
samples t-test was used to determine clinically significant differences in numerical pain 
scores pre- and postepidural insertion with initial loading dose in the ropivacaine group.  
Pre- and postepidural numerical pain scores indicated mean scores of 9.0 and 1.1, 
respectively (Table 2).       
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Numerical pain scores before and after the intervention and number of top-off 
boluses were also recorded on the first page of the anesthetic record (Appendix A).  A 
paired samples t-test was used to determine clinically significant differences in numerical 
pain scores pre- and postepidural insertion with initial loading dose in the bupivacaine 
with fentanyl group.  Pre- and postepidural numerical pain scores in the bupivacaine with 
fentanyl group indicated mean scores of 8.7 and 0.9, respectively (Table 2).   
Table 2 
 
Pre and post pain scores 
    Mean  Significance  Degrees of Freedom 
Pre-epidural ropivacaine   9.0       p<0.01   31 
Post-epidural ropivacaine   1.1     
 
Pre-epidural bupivacaine   8.7       p<0.01   28 
Post-epidural bupivacaine   0.9 
________________________________________________________________________ 
 
Project Objective 2 
 In the ropivacaine group, approximately 19% of the 32 parturient women did not 
require top-off boluses.  However, 71% of the parturient women required at least one top-
off bolus to achieve adequate pain control indicated on a histogram (Figure 1).  In the 
bupivacaine with fentanyl group, 90% of the 29 parturient women did not require top-off 
boluses, while only 10% required at least one top-off bolus to achieve adequate pain 
control (Figure 2) 
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Figure 1.  Top-off boluses of parturient women at SCH ropivacaine group.   
 
Figure 2.  Top-off boluses of parturient women at SCH bupivacaine with fentanyl group.   
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I collected data for the ropivacaine group from retrospective chart reviews based 
on a 1 month (January 2015) audit of all participants who received epidurals for labor and 
met all inclusion/exclusion criteria.  I considered a 1 month audit as adequate given that 
the average number of deliveries at SCH ranged from 30 to 45 per month consistently 
over the past 2 years.  I also collected data for the bupivacaine with fentanyl group 
prospectively in the latter half of mid December 2016 through mid-January 2017 for a 
total of 4 weeks based on a convenience sampling of all participants who received 
epidurals for labor.  The purpose in the timing of the retrospective January audit was to 
align as much as possible seasonal deliveries in accordance with the planned prospective 
portion of the project.       
Discussion of Findings in the Context of Literature and Frameworks 
 The literature strongly supported that bupivacaine is a popular local anesthetic 
that is used in obstetrical anesthesia due to its superior analgesic effects (Dickinson, 
Paech, Mcdonald, & Evans, 2003).  Bupivacaine has a long-standing, successful track 
record and a wide variety of uses alongside maternal labor.  However, its cardiotoxic 
effects when given in high concentrations have pushed for the creation of an isomer, 
ropivacaine.  The main advantage of ropivacaine is its wide margin of safety and motor 
sparing effects, something that is attractive in obstetrical anesthesia.  Most studies 
indicate an equivalent analgesic effect when ropivacaine and bupivacaine are compared 
to each other (Dickinson, Paech, Mcdonald, & Evans, 2003; Catterall & Mackie, 2006; 
Finegold, Mandell, & Ramanathan, 2000).   
The results of the numeric pain score analysis showed that both ropivacaine and 
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bupivacaine with fentanyl groups were equally effective in the treatment of labor pain 
within the first hour after the intervention.  However, the ropivacaine group had higher 
occurrences of rebolus demands, while the bupivacaine with fentanyl group had only a 
minimal amount.  Sample sizes of both groups were very similar and the results of the 
analysis correlate with patient and staff verbal feedback regarding medication efficacy.  
Additionally, parturient women in the bupivacaine with fentanyl group did not experience 
cardiotoxic or excessive motor block effects.  The results correlate with Merson’s (2001) 
study where bupivacaine provides better duration and quality of labor analgesia relief 
than ropivacaine.   
The theoretical framework used for the project was the JHNEBP, which consists 
of three major components: practice, research, and education (Buchko & Robinson, 
2012).  The model accounts for both research and nonresearch factors and both internal 
and external factors in the context of clinical decision-making (Bondmass, 2011).  In the 
first component of the model, practice question, I addressed the topics of effective labor 
analgesia relief and which medication was considered more effective in providing labor 
pain relief, ropivacaine or bupivacaine with fentanyl.  In the second component, 
evidence, I incorporated both research and non-research factors, such as findings from the 
literature and patient/staff verbal feedback.  Lastly, in the third component, translation, I 
focused on whether bupivacaine with fentanyl was feasible for implementation and 
sustainable.  The pharmacy department and anesthesia staff were interviewed to receive 
feedback on long-term purchasing and practice issues.   




 Advanced practice nurses possess the knowledge, skills, and experience regarding 
research and evidence based practice, allowing them to be powerful advocates for 
healthcare policies (Terry, 2015).  Healthcare policies contribute the framework for 
delivery of healthcare services whether in governmental regulations and/or institutional 
standards or procedures (Terry, 2015).  In the end, they either enhance or impede 
healthcare delivery to patient populations.  Utilizing those instruments to their full 
potential is a challenge that all DNPs should undertake.   
This DNP project was a quality improvement initiative aimed at evaluating the 
effectiveness of a new service line medication, bupivacaine with fentanyl, for parturient 
women in a rural community hospital in southern California.  The QI project is one of 
many examples of how advanced practice nurses can be engaged where policy decisions 
are made that influence and shape how rules govern nursing at an institution.  Taking into 
consideration the safety profiles of new medications administered in an especially 
vulnerable patient population is of utmost importance.  The institution should have some 
sort of formal and organized manner of evaluating the effectiveness of new medications 
while also monitoring and documenting unwanted side effects.  Decreasing or 
minimizing the amount of adverse medication reactions while improving patient 
satisfaction is aligned with the institution’s vision and goals and also with the Institute of 
Medicine’s (2001) stance on nurses being champions of policy and social change.  
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Practice  
 The bupivacaine with fentanyl initiative provided evidence that sometimes newer 
and often more expensive medications do not necessarily provide better outcomes or 
improve patient/provider satisfaction.  The initiative showed that a methodical and logical 
process could be implemented to evaluate the effectiveness of new service line 
medications administered in clinical practice.  The DNP curriculum emphasizes 
leadership for evidence-based practice, which involves the translation of research into 
practice, the evaluation of evidence, the application of research in clinical decision-
making, and the implementation of innovative methods and tools to change practice 
(Zaccagnini & White, 2011).  From the results of the initiative, an older and less 
expensive medication provided less top-off boluses, which in turn provided more 
sustainable labor pain relief in parturient women at SCH.   
Research 
 For the DNP clinician, selection of the research problem is arguably the most 
crucial element in the research process (Terry, 2015).  If the selected problem is not 
viable and testable, the whole process can waste valuable hours and financial resources 
while also creating frustration for the researcher.  The core of the idea may come from 
patients, fellow colleagues, or from an indirect source, such as auditing, if the provider 
works in a quality management or administration role (Fitzpatrick & Whall, 2005).  In 
this case, the problem stemmed from both direct and indirect sources.   
The results of the QI project showed that bupivacaine with fentanyl was more 
effective in providing sustainable labor pain relief as compared to ropivacaine, thereby 
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improving the quality of care at SCH.  This finding is contrary to most current evidence 
in mainstream literature (Eddleston et al., 1996; Owen, D’Angelo, & Geranchar, 1998; 
Polley, Columb, Naughton, Wagner, & Van de Ven, 1999; Dresner et al., 2000; Fehder & 
Gennaro, 1993), which suggests that ropivacaine is equipotent to bupivacaine with less 
side effects and motor sparing benefits.  Future research needs to be conducted to show 
the effectiveness of administering bupivacaine with fentanyl in a larger Morongo Basin 
population over a longer period of time to determine generalizability and reliability.  The 
results can then determine if bupivacaine with fentanyl does provide more sustainable 
labor pain relief in parturient women.  Future research may also explore motor sparing 
effects, hemodynamics, patient satisfaction, and conversion to cesarean sections.    
Social Change 
The first implication for social change was the collaboration of other clinical 
providers to change practice using the evidence.  Today’s complexity of healthcare 
demands inter and intraprofessional collaboration to improve and sustain best outcomes 
for high quality care (Wojciechowski, Pearsall, Murphy, & French, 2016).  Teams 
involved in continuous quality improvement projects may magnify and reveal competing 
mindsets of individuals and different practice strategies.  However, in dynamic healthcare 
environments, individuals and systems need to be fluid and adaptable.  Improvement is a 
never-ending journey that staff members need to be made aware of.  With leadership 
support, the goal is for all participants to contribute to problem solving and to improve 
the design that adds value as defined by the client (Toussaint & Gerard, 2010).     
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The second implication for social change was to improve the quality of care for 
parturient women in the Morongo Basin community by also addressing the fear and 
anxiety of childbirth pain.  Childbirth pain is a complex phenomenon that can trigger fear 
to those who have not experienced it.  The fear is real, considered harmful, and has been 
shown to affect a woman’s self-esteem and the ability to handle labor pain effectively 
(Karlsdottir, Halldorsdottir, & Lundgren, 2014).  Unmet expectations and negative birth 
experiences have been shown to influence women’s decisions about future childbearing 
(Gottvall & Waldenstrom, 2002).  With the Information received from the project, I 
would be able contribute to the body of nursing knowledge aimed at improving health 
care quality for the parturient and her family in an emotionally significant period in their 
lives.  When providers place epidurals for labor and administer safe and effective 
medications, they can allay patients’ fears and anxiety during hospitalization where levels 
of vulnerability are high.  Treating labor pain effectively with safe medications, 
informing parturient women adequately by addressing their concerns, and presenting 
realistic expectations about epidural pain management may increase satisfaction 
surrounding the childbirth experience.  
Project Strengths and Limitations  
Strengths 
Strengths of the project were the use of the numeric pain rating scale and the 
implementation, collection, and analysis of project data by one lead project provider.  The 
numeric pain rating scale is a trusted, long standing diagnostic tool that has been used in 
numerous disciplines and practices to evaluative subjective pain (Buchko & Robinson, 
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2012).  Since a numeric value is placed in correlation with the pain, degrees of pain can 
be distinguished from one another.  Hence, higher scores can indicate greater pain 
intensity.  I implemented the same practice technique for the prospective bupivacaine 
with fentanyl group, such as placement of epidurals at similar levels of the spine, initial 
bolus amounts, fluid pre-loading in participants, and communication between myself and 
participants.  Consistent practices ensure less confounding variables.   
Limitations 
There were two main limitations to the project.  First, the data collected from the 
retrospective ropivacaine group had less credibility due to confounding variables.  
Although retrospective studies allow investigators to quickly use past data conveniently 
to inform current research questions, the database should be used based on sound 
rationale (Abbott, Barton, Terhorst, & Shembel, 2016).  A few considerations include 
relevant data sources, data extraction methods, statistical procedures, and cautious 
interpretation of the findings.  Although initial medication boluses and collection of 
numeric pain scale scores at designated times were similar to the prospective bupivacaine 
with fentanyl group, multiple providers placed the epidurals, communication between the 
providers and patients were most likely different, basal rate infusions varied between 
patients depending on provider preferences, and fluid pre-loading was sometimes omitted 
or not charted.  Additionally, retrospective studies generally do not have the 
methodological rigor that is necessary to eliminate bias (Abbott, Barton, Terhorst, & 
Shembel, 2016).  However, that is not to say that the information extracted from 
retrospective studies are not valuable.  Through the retrospective audit of ropivacaine 
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patients, I offered preliminary findings that base clinical importance on the detection, 
management, and therapy of labor pain in parturient women at SCH.        
Second, a convenience sampling was used for the project in both retrospective 
and prospective portions of the project due to time and resource constraints.  A 
retrospective audit was necessary for the ropivacaine group because the medication was 
discontinued in January 2015 at SCH.  The prospective portion of the project was feasible 
with the bupivacaine group, which comes with more rigor and control for bias.  However, 
due to the low volume of deliveries at the institution, a convenience sampling was used to 
decrease the level of sampling error.  To offer some control and limit selection bias of the 
prospective portion of the project, I selected some stringent inclusion and exclusion 
criteria and collected participant data over four weeks each.  Despite some of those 
measures, I collected data from a rural community hospital that may not be representative 
of the community at large further limiting the generalizability of the findings.  An 
accurate study needs to include all facets of a population with randomization (Polit, 
2010).  To add generalizability of the results, project teams would need to include 
randomization of participants with standardized practice techniques of providers.   
Recommendations for Remediation of Limitations in Future Work 
A major limitation of the QI project was the comparison of two different 
medications from a retrospective and prospective standpoint.  There is less control with 
retrospective studies as compared to prospective studies.  Provider biases, practice 
techniques, communication, and fluid prebolusing can differ greatly and be widely 
inconsistent.  Researchers who use prospective approaches have more control of 
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confounding variables and have more precise estimates about the outcomes or relative 
risks of outcomes based on exposure (Grove et al., 2013).   
A more reliable and more generalizable project would be the comparison of both 
medications strictly from a prospective approach over a longer period of time with the 
randomization of larger sample sizes.  Providers would need to implement a standardized 
technique of epidural placement and adhere to consistent communication and 
preintervention protocols.  However, the challenge of performing a larger scale, more 
time consuming project as such would require adequate support from institution 
stakeholders, management, and most importantly, cooperation from anesthesia providers 
and labor/delivery RNs.  Those involved in the project would need to present expected 
outcomes and benefits of the project in a clear manner and aligned with the institution’s 
vision and goals.           
Analysis of Self 
As Scholar 
Society benefits through scholarship of practice when practitioners give expert 
nursing care, evaluate, and constantly improve practice based on evidence-based 
knowledge (Loomis, Willard, & Cohen, 2007).  Proponents of the DNP degree posit that 
nursing scholarship would be enhanced and advanced through doctoral nursing 
education, which would raise advanced nursing practice to new levels termed by the 
American Association of Colleges of Nursing (AACN) as ‘scholarship of engagement’ 
(AACN, 2006).  Scholarships of engagement occur when theory and research are applied 
to clinical settings, tested, amended, and extended (Loomis et al., 2007). 
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Throughout the DNP program, I have gained a wealth of didactic knowledge that 
could be shared with other colleagues to improve patient outcomes and enhance quality 
of care.  With the aging population and projected demographic shifts, the demand for 
advanced practice nurses and their practice requirements will only increase furthering the 
need for additional education.  Advanced practice nurses are prepared to work in a 
variety of roles once they complete a doctoral program that incorporates research 
elements into clinical practice.  I have also learned valuable problem solving approaches 
and how to search for evidence based knowledge using systematic methods.  The 
information obtained could also be shared with institution leaders and other community 
stakeholders.  In turn, I shared methods of searching for high levels of evidence to other 
colleagues so they too could explore feasible solutions to clinical problems. 
As Practitioner 
Practitioners who complete the DNP curriculum are ready for the acceptance of 
new advanced practice roles.  Some of the major roles are at their place of employment or 
healthcare organization and may involve duties such as, influencing healthcare and policy 
development, providing leadership, and strengthening interdisciplinary relationships with 
other professionals (Kaplan & Brown, 2009).  The DNP prepared nurse who conducts 
practice and provide care according to the AACN essentials will bring added value to 
practice environments and patients.  Intangible values include quality and safety 
improvement, healthcare institution savings, and improved patient relationships (Mackey, 
2009).   
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 As a practitioner, the clinical experiences have given me a broader look at 
healthcare systems operations, workflow efficiency, outdated policies, and a way of 
sensing workplace culture.  It has made me keenly aware of the need to develop rapport 
and effective communication skills with stakeholders and front line clinical staff in order 
to accomplish objectives.  Those invaluable skills are not taught in textbooks but only 
learned through experiences. 
As Project Developer 
Project developers have many roles and responsibilities.  His/her main goals are 
to handle tasks that move the project along toward successful completion while reaching 
project objectives.  As a project developer, I had to understand the inner dynamics of the 
project, remind myself of the objectives, learn to communicate with leaders/management 
of the institution to move things forward, and allow those who have valuable skills to use 
them.  Morrill, Taege, & Slater (2010) note that trained, supportive staff and the 
acceptance of policies mixed with environmental changes help achieve successful 
outcomes.  
Adoption of the project is a big step in having the organization consider taking a 
small test of change (Terry, 2015).  There were some unexpected delays and frustration 
when it came to approval and implementation of the project.  I realized how important it 
was in identifying barriers early in the process, setting up realistic expectations, and 
appreciating the value of forming good relationships with leaders and stakeholders in the 
institution.  Leadership, management, and development often overlap.  Ultimately, I 
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realized that without the authority that stems from leadership and management, my 
project may have shown potential but never materialized.            
What does this project mean for future professional development? 
The DNP project has given me a strong foundation and experience for future 
projects and initiatives.  I was able to develop closer professional relationships with key 
stakeholders and leaders of the institution who believe in high quality, cost-effective care.  
They have already voiced their desire for me to be involved in several upcoming 
institution projects.  More importantly, I have learned to systematically search, review, 
interpret, plan, and implement new or existing evidence in clinical practice.  Evidence-
based practice has become prominent in many professions, with the emphasis on clinical 
decision-making based on the best available evidence from systematic research 
(Zaccagnini & White, 2012).  I have learned that management’s use of the evidence just 
takes it to the next level where parameters are defined for what evidence will be collected 
and how the data will be utilized for monitoring, measuring performance, and evaluating.  
The data needs to be captured, quantified, and placed on a spreadsheet in a comparative 
format to understand if something works or does not work.  I have great satisfaction and a 
feeling of professional fulfillment when I present new evidence to the institution so an 
actual policy is created.  
Summary and Conclusions  
The overall goal of the development and implementation of the bupivacaine with 
fentanyl project was for me to explore the effectiveness of the new service line 
medication, bupivacaine 0.1% with fentanyl 2mcg/ml, administered via PCEA infusion in 
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parturient women at SCH.  There were two objectives for the project.  The first objective 
was to achieve verbal pain scores of less than four out of 10 on a numeric pain scale 
ranging from zero to 10 within 60 minutes of epidural insertion and initial loading dose.  
The second objective was to achieve a rebolus rate of less than 10% throughout the 
remainder of the course of labor until the delivery of the fetus.  I collected data for the 
ropivacaine group from retrospective chart reviews based on a 1 month January 2015 
audit of all participants who received epidurals for labor and met all inclusion/exclusion 
criteria.  I also collected data for the bupivacaine with fentanyl group prospectively in 
mid December 2016 based on a convenience sampling of all participants who received 
epidurals for labor.   
I incorporated a quantitative, time-series design to determine causal or 
correlational relationships between independent and dependent variables.  Thirty-two 
participants were included in the ropivacaine group, while 16 participants were included 
in the bupivacaine with fentanyl group for analyses.  The results indicated that both 
ropivacaine and bupivacaine with fentanyl were statistically effective in relieving labor 
pain to adequate levels initially.  However, the high number of rebolus rates for patients 
in the ropivacaine group indicate that bupivacaine with fentanyl provides more 
sustainable labor pain relief in parturient women at SCH.   
The academic and clinical preparation gleaned from the DNP curriculum has 
enabled me to use a wide array of knowledge from the sciences and translate them 
quickly to clinical practice.  Patient populations and healthcare systems benefit from the 
evidence.  The DNP curriculum has also helped me to develop, implement, and evaluate 
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new clinical practice approaches based on nursing theories and theories from other 
disciplines.  I look forward to furthering my professional development, promoting health 
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Section 5: Scholarly Product 
Communicating the findings of a research or quality improvement project is the 
final step, which involves developing a report and disseminating it through presentations 
and/or publications to a vast array of audiences, such as, policymakers, healthcare 
professionals, and healthcare consumers (Grove, Burns, & Gray 2013).  Presentations and 
published findings help advance the knowledge of a discipline by providing evidence-
based practice.  Furthermore, dissemination of the findings helps promote the critical 
analysis of previous reports or studies, fosters the reproduction of studies, and points out 
additional problems (Melnyk & Fineout-Overholt, 2010).  Because the QI project was 
completed at SCH to determine the efficacy of a new service line medication, I will 
present the findings to the institution’s governing board and surgical services staff at the 
quarterly medical executive committee meeting.  I will generate an abbreviated report 
and give an oral presentation via PowerPoint media.  PowerPoint slides are an excellent 
layout of the project due to easy-to-read fonts, visuals and figures to amplify points, and 
creative backgrounds (Grove, Burns, & Gray 2013).  Additionally, the abbreviated report 
is to be published in the monthly hospital newsletter.  Publication of the findings will 
alert healthcare consumers of SCH and the Morongo Basin community that quality 
improvement and patient safety/satisfaction is of utmost importance to the organization 
and the community.   
Another setting where findings could be communicated is the annual spring 
conference of the California Association of Nurse Anesthetists (CANA) through poster 
presentations (Figure 3).  The CANA expresses visions about leadership, advocacy, and 
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education for nurse anesthetists in California.  Poster presentations allow researchers 
and/or clinicians to share preliminary findings, answer questions, and interact with other 
researchers or providers about their studies (Grove, Burns, & Gray 2013).           
 
Figure 3.  Bupivacaine with fentanyl quality improvement poster of parturient women in 







RESEARCH POSTER PRESENTATION DESIGN © 2015 
www.PosterPresentations.com 
Epidurals used for labor is a common regional anesthesia technique that is 
easy to control and fairly easy to place, while providing the most reliable 
method of pain relief in obstetrics for laboring parturients (Fehder & Gennaro, 
1993 ).  Local anesthetics, narcotics, and/or combinations of the two are 
administered through epidurals to treat labor pain.  Hence, the choice of 
medication is important, which can highly influence outcomes of pain relief.  
 
Ropivacaine has been in use for approximately 1.5 years at SCH after 
discontinuation of bupivacaine 0.125 percent with fentanyl 1.6 mcg/ml.  Since 
the medication change, anesthesia peers and labor/delivery registered nurses 
(RNs) have voiced dissatisfaction.  Anesthesia peers stated that they had 
higher workload demands because parturients treated with ropivacaine often 
require more top off boluses of bupivacaine 0.25 percent to provide adequate 
pain relief.  However, top off boluses are not long-term solutions and are only 
effective up to approximately 60 minutes.  Eventually, ropivacaine was 




A prospective, time-series, quantitative design was used to explore the 
efficacy of a new service line medication, bupivacaine 0.1 percent with 
fentanyl 2mcg/ml, in laboring parturients.  
 
Verbal pain scores that were reported to the anesthesia provider just prior to 
the bolus and an hour after epidural administration and initial bolus were 
recorded and statistically analyzed through paired samples t tests to determine 
clinically significant differences.  
 
Ropivacaine data was based on retrospective chart audits for one month. 
Bupivacaine with fentanyl data was based on prospective information 
collected by one provider for one month. 
 
  Framework 
 
The theoretical framework used for the project was the Johns Hopkins 
Nursing evidence-based practice model (JHNEBP).  The first component of 
the model, practice question, addressed the topics of effective labor analgesia 
relief and which medication was considered more effective in providing labor 
pain relief, ropivacaine or bupivacaine with fentanyl.  The second component, 
evidence, incorporated both research and non-research factors, such as 
findings from the literature and patient/staff verbal feedback.  The third 
component, translation, focused on whether bupivacaine with fentanyl was 
feasible for implementation.  The pharmacy department and anesthesia staff 
were interviewed to receive feedback on long-term purchasing and practice 




The initiative focused on all parturients in the Morongo basin community 
admitted for labor at a fifty-five-bed rural community hospital in Southern 
California. The retrospective component of the initiative was based on a one-
month chart audit convenience sampling of parturients who received epidurals 
from multiple providers and were placed on ropivacaine solutions.  The 
prospective component of the initiative based on a one-month convenience 
sampling of parturients who labor at SCH, receive epidurals from one 




- One anesthesia provider collected the entire data for both retrospective and 
prospective components of the initiative. 
- The retrospective component involved chart audits in January 2015 
accessed through “idoc”. 
- The prospective component involved data collection from parturients in 
mid December to mid January 2017. 
- Verbal pain scores were obtained five minutes prior to epidural insertion 
and one-hour post epidural insertion and initial medication bolus.  Data on 





- Thirty-two participants were included in the ropivacaine group while 
twenty-nine participants were included in the bupivacaine with fentanyl 
group for analysis.    
- Ages of the participants in the ropivacaine group ranged from 18 to 36 
years old with a mean age of 25.3.   
- Ages of the participants ranged from 19 to 33 years old with a mean age of 
25. 
- Pre and post epidural numerical pain scores for the ropivacaine group 
indicated mean scores of 9.0 and 1.1, respectively. 
- Pre and post epidural numerical pain scores in the bupivacaine with 
fentanyl group indicated mean scores of 8.7 and 0.9, respectively. 
- In the ropivacaine group, approximately 19 percent of the 32 parturients 
did not require top-off boluses.  However, 71 percent of the parturients 
required at least one top-off bolus to achieve adequate pain control 
indicated on a histogram (Figure 1).  
- In the bupivacaine with fentanyl group, 90% of the 29 parturients did not 
require top-off boluses, while only 10 percent required at least one top-off 
bolus to achieve adequate pain control (Figure 2).  
         Figure 1 
Data/Results Conclusions 
The results of the numeric pain score analysis showed that both ropivacaine 
and bupivacaine with fentanyl groups were equally effective in the treatment 
of labor pain within the first hour after the intervention.  However, the 
ropivacaine group had higher occurrences of rebolus demands, while the 
bupivacaine with fentanyl group had only a minimal amount.  Sample sizes of 
both groups were very similar and the results of the analysis correlate with 
patient and staff verbal feedback regarding medication efficacy.  Additionally, 
parturients in the bupivacaine with fentanyl group did not experience 
cardiotoxic or excessive motor block effects.  The results correlate with 
Merson’s (2001) study where bupivacaine provides better duration and quality 
of labor analgesia relief than ropivacaine.   
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To determine the efficacy of the new service line medication, bupivacaine 0.1 
percent with fentanyl 2mcg/ml, for the treatment of labor pain in parturients at 
SCH and to create positive labor experiences for parturients by treating labor 
pain with medications that have good safety profiles, are cost-effective, and 
require minimal to almost no additional top off boluses.  Effective pain relief 
medications will allow patients to allocate more quality time to other areas of 
labor such as breathing and relaxation techniques.  For healthcare providers, 
effective pain relief would decrease time demands in providing comfort 
measures, which may permit more time for coaching and individualized care.  
 
Significance to Practice 
 
Although much of the medical literature notes that ropivacaine has a similar 
potency and duration to that of bupivacaine with less cardiotoxic effects 
(Dresner et al., 2000), the reverse seems true at SCH.  Implementation of a 
bupivacaine initiative to investigate its role in labor analgesia relief would add 
to the ever-increasing knowledge base aimed at providing high quality care at 
cost effective means.  Finding a suitable medication that would provide 
adequate analgesia needing less frequent rebolusing of additional local 
anesthetics improves quality of care by decreasing exposure of unnecessary 





1. To achieve verbal pain scores of the parturients of less than four out of ten 
post epidural insertion/initial loading dose within sixty minutes.  
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Figure 3.  Bupivacaine with fentanyl quality improvement poster of parturient women in 
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Epidurals used for labor is a common regional anesthesia technique that is 
easy to control and fairly easy to place, while providing the most reliable 
method of pain relief in obstetrics for laboring parturients (Fehder & Gennaro, 
1993 ).  Local anesthetics, narcotics, and/or combinations of the two are 
administered through epidurals to treat labor pain.  Hence, the choice of 
medication is important, which can highly influence outcomes of pain relief.  
 
Ropivacaine has been in use for approximately 1.5 years at SCH after 
discontinuation of bupivacaine 0.125 percent with fentanyl 1.6 mcg/ml.  Since 
the medication change, anesthesia peers and labor/delivery registered nurses 
(RNs) have voiced dissatisfaction.  Anesthesia peers stated that they had 
higher workload demands because parturients treated with ropivacaine often 
require more top off boluses of bupivacaine 0.25 percent to provide adequate 
pain relief.  However, top off boluses are not long-term solutions and are only 
effective up to approximately 60 minutes.  Eventually, ropivacaine was 




A prospective, time-series, quantitative design was used to explore the 
efficacy of a new service line medication, bupivacaine 0.1 percent with 
fentanyl 2mcg/ml, in laboring parturients.  
 
Verbal pain scores that were reported to the anesthesia provider just prior to 
the bolus and an hour after epidural administration and initial bolus were 
recorded and statistically analyzed through paired samples t tests to determine 
clinically significant differences.  
 
Ropivacaine data was based on retrospective chart audits for one month. 
Bupivacaine with fentanyl data was based on prospective information 
collected by one provider for one month. 
 
  Framework 
 
The theoretical framework used for the project was the Johns Hopkins 
Nursing evidence-based practice model (JHNEBP).  The first component of 
the model, practice question, addressed the topics of effective labor analgesia 
relief and which medication was considered more effective in providing labor 
pain relief, ropivacaine or bupivacaine with fentanyl.  The second component, 
evidence, incorporated both research and non-research factors, such as 
findings from the literature and patient/staff verbal feedback.  The third 
component, translation, focused on whether bupivacaine with fentanyl was 
feasible for implementation.  The pharmacy department and anesthesia staff 
were interviewed to receive feedback on long-term purchasing and practice 




The initiative focused on all parturients in the Morongo basin community 
admitted for labor at a fifty-five-bed rural community hospital in Southern 
California. The retrospective component of the initiative was based on a one-
month chart audit convenience sampling of parturients who received epidurals 
from multiple providers and were placed on ropivacaine solutions.  The 
prospective component of the initiative based on a one-month convenience 
sampling of parturients who labor at SCH, receive epidurals from one 




- One anesthesia provider collected the entire data for both retrospective and 
prospective components of the initiative. 
- The retrospective component involved chart audits in January 2015 
accessed through “idoc”. 
- The prospective component involved data collection from parturients in 
mid December to mid January 2017. 
- Verbal pain scores were obtained five minutes prior to epidural insertion 
and one-hour post epidural insertion and initial medication bolus.  Data on 





- Thirty-two participants were included in the ropivacaine group while 
twenty-nine participants were included in the bupivacaine with fentanyl 
group for analysis.    
- Ages of the participants in the ropivacaine group ranged from 18 to 36 
years old with a mean age of 25.3.   
- Ages of the participants ranged from 19 to 33 years old with a mean age of 
25. 
- Pre and post epidural numerical pain scores for the ropivacaine group 
indicated mean scores of 9.0 and 1.1, respectively. 
- Pre and post epidural numerical pain scores in the bupivacaine with 
fentanyl group indicated mean scores of 8.7 and 0.9, respectively. 
- In the ropivacaine group, approximately 19 percent of the 32 parturients 
did not require top-off boluses.  However, 71 percent of the parturients 
required at least one top-off bolus to achieve adequate pain control 
indicated on a histogram (Figure 1).  
- In the bupivacaine with fentanyl group, 90% of the 29 parturients did not 
require top-off boluses, while only 10 percent required at least one top-off 
bolus to achieve adequate pain control (Figure 2).  
         Figure 1 
Data/Results Conclusions 
The results of the numeric pain score analysis showed that both ropivacaine 
and bupivacaine with fentanyl groups were equally effective in the treatment 
of labor pain within the first hour after the intervention.  However, the 
ropivacaine group had higher occurrences of rebolus demands, while the 
bupivacaine with fentanyl group had only a minimal amount.  Sample sizes of 
both groups were very similar and the results of the analysis correlate with 
patient and staff verbal feedback regarding medication efficacy.  Additionally, 
parturients in the bupivacaine with fentanyl group did not experience 
cardiotoxic or excessive motor block effects.  The results correlate with 
Merson’s (2001) study where bupivacaine provides better duration and quality 
of labor analgesia relief than ropivacaine.   
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To determine the efficacy of the new service line medication, bupivacaine 0.1 
percent with fentanyl 2mcg/ml, for the treatment of labor pain in parturients at 
SCH and to create positive labor experiences for parturients by treating labor 
pain with medications that have good safety profiles, are cost-effective, and 
require minimal to almost no additional top off boluses.  Effective pain relief 
medications will allow patients to allocate more quality time to other areas of 
labor such as breathing and relaxation techniques.  For healthcare providers, 
effective pain relief would decrease time demands in providing comfort 
measures, which may permit more time for coaching and individualized care.  
 
Significance to Practice 
 
Although much of the medical literature notes that ropivacaine has a similar 
potency and duration to that of bupivacaine with less cardiotoxic effects 
(Dresner et al., 2000), the reverse seems true at SCH.  Implementation of a 
bupivacaine initiative to investigate its role in labor analgesia relief would add 
to the ever-increasing knowledge base aimed at providing high quality care at 
cost effective means.  Finding a suitable medication that would provide 
adequate analgesia needing less frequent rebolusing of additional local 
anesthetics improves quality of care by decreasing exposure of unnecessary 
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Appendix A:  Pre-anesthesia Evaluation Form 
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Appendix B:  Numeric Pain Rating Scale 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
